Pulmatrix (PULM) vs Universe Pharmaceuticals (UPC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Universe Pharmaceuticals is the larger company by market cap ($5.4 million vs $4.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PULM | UPC |
|---|---|---|
| Share price | $1.27 | $1.08 |
| Market cap | $4.64M | $5.43M |
| 1-day change | -10.56% | -20.59% |
| YTD return | — | -71.65% |
| 1-year return | — | -68.24% |
| 5-year return | — | -99.99% |
| EPS (TTM) | $-1.20 | $-1.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $17.86B |
| Revenue growth (YoY) | — | -22.44% |
| Net income (latest FY) | $-5.16M | $-3.67B |
| Gross margin | — | 35.28% |
| Operating margin | — | -16.33% |
| Net margin | — | -20.56% |
| 52-week high | $4.94 | $17.96 |
| 52-week low | $1.06 | $1.05 |
| Distance from 52-week high | -74.29% | -93.99% |
| Average volume | 35.45K | 176.76K |
| Shares outstanding | 3.65M | 5.01M |
| Employees | 2 | 216 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Pulmatrix
PULM stock →Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
About Universe Pharmaceuticals
UPC stock →Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.
Health Care · Biotechnology: Pharmaceutical Preparations · 216 employees
PULM vs UPC FAQ
Which is bigger, Pulmatrix or Universe Pharmaceuticals?
Universe Pharmaceuticals (UPC) is larger, with a market capitalization of $5.43M compared with $4.64M for Pulmatrix (PULM).
Are Pulmatrix and Universe Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.